SCHEMBL25259519

SCHEMBL25259519

CC(C)n1cnc2c(NCc3ccc(-c4ccncc4)cn3)nc(-c3cccnc3)nc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 17/20 0.55
CCNE1 P24864 14/20 0.55
CCNE2 O96020 6/20 0.55
CCNA2 P20248 5/20 0.55
CCNA1 P78396 5/20 0.55
CDK9 P50750 4/20 0.49
CCNK O75909 2/20 0.49
CDK12 Q9NYV4 2/20 0.49
CDK1 P06493 10/20 0.47
CDK4 P11802 9/20 0.47
CDK7 P50613 9/20 0.47
CCNH P51946 8/20 0.47
MAPK1 P28482 8/20 0.47
CCNB1 P14635 8/20 0.47
CCND1 P24385 7/20 0.47
CCNT1 O60563 2/20 0.47
CDK5 Q00535 2/20 0.47
MNAT1 P51948 1/20 0.47
CDK6 Q00534 1/20 0.47
CCNB2 O95067 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30518558 1.00 CDK2 (0.55) CDK2CCNE1CCNE2CCNA2CCNA1
SCHEMBL25309378 0.96 CDK2 (0.56) CDK2CCNE1CCNE2CCNA2CCNA1
SCHEMBL30518560 0.96 CDK2 (0.56) CDK2CCNE1CCNE2CCNA2CCNA1
SCHEMBL30518554 0.93 CDK2 (0.53) CDK2CCNE1CCNE2CCNA2CCNA1
SCHEMBL25308603 0.93 CDK2 (0.53) CDK2CCNE1CCNE2CCNA2CCNA1
SCHEMBL25309012 0.91 CDK2 (0.50) CDK2CCNE1CCNE2CCNA2CCNA1
SCHEMBL30518540 0.91 CDK2 (0.50) CDK2CCNE1CCNE2CCNA2CCNA1
SCHEMBL25306155 0.89 CDK2 (0.51) CDK2CCNE1CCNE2CCNA2CCNA1
SCHEMBL30518549 0.89 CDK2 (0.51) CDK2CCNE1CCNE2CCNA2CCNA1
SCHEMBL25307772 0.86 CDK2 (0.61) CDK2CCNE1CCNE2CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101023-A1 HETEROARYL DERIVATIVE AND USES THEREOF IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) 2025-03-27 US claimed
WO-2023140640-A1 HETEROARYL DERIVATIVE AND USES THEREOF 한양대학교 산학협력단 2023-07-27 WO claimed
US-20250101023-A1 HETEROARYL DERIVATIVE AND USES THEREOF IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) 2025-03-27 US disclosed
WO-2023140640-A1 HETEROARYL DERIVATIVE AND USES THEREOF 한양대학교 산학협력단 2023-07-27 WO disclosed
WO-2023140640-A1 HETEROARYL DERIVATIVE AND USES THEREOF 한양대학교 산학협력단 2023-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101023-A1 HETEROARYL DERIVATIVE AND USES THEREOF ERBB2, ERBB3, FGFR2 CDK2 79/4885CCNE1 1403/4885CCNE2 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.